All Posts Tagged With: "EVVV"
(JNJ) Johnson & Johnson Announces They Will Aquire Micrus Endovascular
Johnson & Johnson (JNJ) recently announced plans to acquire medical devices maker Micrus Endovascular Corp. (MEND), based in San Jose,...
(EVVV) ev3 Files for FDA Pre-Market Approval
ev3, Inc. (EVVV) has recently filed the final module of its Pre-market Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for its Pipeline Embolization Device. The company expects...
(EVVV) ev3 Enters Agreement With MEDRAD
ev3, Inc. (EVVV) recently entered a new agreement with MEDRAD, Inc. Per the agreement, ev3’s SilverHawk and TurboHawk Plaque Excision Systems will be used in combination with MEDRAD’s Cotavance peripheral...
(EVVV) ev3 Analyst Downgrades to Neutral
We have recently downgraded ev3 Inc. (EVVV) to Neutral with a target price of $16 based on a P/E of roughly 35.6x our fiscal 2010 EPS estimate of 45 cents. We downgraded the stock based on a downtrend in...
(EVVV) ev3 Reports Earnings In-Line With Consensus
ev3, Inc. (EVVV) recently reported fourth quarter and full fiscal 2009 results. For the fourth quarter, earnings per share were 12 cents, in line with the Zacks Consensus Estimate and higher than the year-ago...
(CSII) Cardiovascular Systems Gets FDA Approval
Cardiovascular Systems, Inc. (CSII) recently received the U.S. Food and Drug Administration’s (FDA) conditional Investigational Device Exemption (IDE) approval. The approval is meant to evaluate the safety...
(EVVV) ev3 Completes TrailBlazer Support Catheter Recall
ev3, Inc. (EVVV) recently completed a voluntary Class I recall of its TrailBlazer Support Catheter. The catheter was recalled as a result of the device cracking near its marker band. ev3 received these complaints...
(EVVV) ev3 Beats Consensus Earnings Estimates
ev3, Inc. (EVVV), the Zacks Bull of the Day for last Friday (October 23rd), reported third quarter 2009 earnings per share of 17 cents, easily beating the Zacks Consensus Estimate of 2 cents and the year-ago...
(CSII) Cardiovascular Systems’ Portfolio Gets Expanded in Marketing Agreement
Yesterday, Cardiovascular Systems Inc. (CSII) announced that it has agreed to market Japan-based Asahi Intecc Co. Ltd’s peripheral guide wire line in the United States. The peripheral guide wires address long, complex lesions above or below the knee, and...
(CSII) Cardiovascular Systems Better Than Expected Results
Cardiovascular Systems, Inc. (CSII) reported better-than-expected results for the fourth quarter of fiscal 2009. For the quarter, its loss per share was 40 cents, better than the Zacks Consensus Estimate of 58 cents and the year-ago loss per share of $2.34.